CVS HEALTH CORP (CVS.DE) Stock Fundamental Analysis

FRA:CVS • US1266501006

66.27 EUR
-0.06 (-0.09%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall CVS gets a fundamental rating of 3 out of 10. We evaluated CVS against 28 industry peers in the Health Care Providers & Services industry. CVS may be in some trouble as it scores bad on both profitability and health. CVS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year CVS was profitable.
  • In the past year CVS had a positive cash flow from operations.
  • CVS had positive earnings in 4 of the past 5 years.
  • Of the past 5 years CVS 4 years had a positive operating cash flow.
CVS.DE Yearly Net Income VS EBIT VS OCF VS FCFCVS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.18%, CVS is doing worse than 71.43% of the companies in the same industry.
  • CVS's Return On Equity of 0.64% is on the low side compared to the rest of the industry. CVS is outperformed by 75.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.90%, CVS is in line with its industry, outperforming 46.43% of the companies in the same industry.
  • CVS had an Average Return On Invested Capital over the past 3 years of 6.22%. This is in line with the industry average of 6.14%.
Industry RankSector Rank
ROA 0.18%
ROE 0.64%
ROIC 4.9%
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
CVS.DE Yearly ROA, ROE, ROICCVS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • With a Profit Margin value of 0.12%, CVS is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
  • CVS's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 2.73%, CVS is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of CVS has declined.
  • The Gross Margin of CVS (13.88%) is worse than 60.71% of its industry peers.
  • In the last couple of years the Gross Margin of CVS has declined.
Industry RankSector Rank
OM 2.73%
PM (TTM) 0.12%
GM 13.88%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
CVS.DE Yearly Profit, Operating, Gross MarginsCVS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • CVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for CVS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CVS.DE Yearly Shares OutstandingCVS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
CVS.DE Yearly Total Debt VS Total AssetsCVS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

  • CVS has an Altman-Z score of 2.26. This is not the best score and indicates that CVS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.26, CVS is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
  • CVS has a debt to FCF ratio of 10.46. This is a negative value and a sign of low solvency as CVS would need 10.46 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 10.46, CVS is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.85 indicates that CVS is somewhat dependend on debt financing.
  • CVS has a Debt to Equity ratio of 0.85. This is comparable to the rest of the industry: CVS outperforms 53.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 10.46
Altman-Z 2.26
ROIC/WACC0.64
WACC7.66%
CVS.DE Yearly LT Debt VS Equity VS FCFCVS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • CVS has a Current Ratio of 0.83. This is a bad value and indicates that CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.83, CVS perfoms like the industry average, outperforming 46.43% of the companies in the same industry.
  • A Quick Ratio of 0.63 indicates that CVS may have some problems paying its short term obligations.
  • The Quick ratio of CVS (0.63) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.63
CVS.DE Yearly Current Assets VS Current LiabilitesCVS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.54% over the past year.
  • The Earnings Per Share has been decreasing by -2.11% on average over the past years.
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.08% on average over the next years. This is quite good.
  • CVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.26% yearly.
EPS Next Y7.28%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
EPS Next 5Y9.08%
Revenue Next Year2.59%
Revenue Next 2Y3.98%
Revenue Next 3Y5.31%
Revenue Next 5Y4.26%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
CVS.DE Yearly Revenue VS EstimatesCVS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100B 200B 300B 400B 500B
CVS.DE Yearly EPS VS EstimatesCVS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 11.65, which indicates a very decent valuation of CVS.
  • Compared to the rest of the industry, the Price/Earnings ratio of CVS indicates a rather cheap valuation: CVS is cheaper than 82.14% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.68. CVS is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 10.86 indicates a reasonable valuation of CVS.
  • 85.71% of the companies in the same industry are more expensive than CVS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, CVS is valued rather cheaply.
Industry RankSector Rank
PE 11.65
Fwd PE 10.86
CVS.DE Price Earnings VS Forward Price EarningsCVS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CVS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 15.86
EV/EBITDA N/A
CVS.DE Per share dataCVS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.6
PEG (5Y)N/A
EPS Next 2Y10.96%
EPS Next 3Y11.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • CVS has a Yearly Dividend Yield of 3.41%.
  • Compared to an average industry Dividend Yield of 1.83, CVS pays a better dividend. On top of this CVS pays more dividend than 89.29% of the companies listed in the same industry.
  • CVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 3.41%

5.2 History

  • The dividend of CVS has a limited annual growth rate of 5.72%.
Dividend Growth(5Y)5.72%
Div Incr Years3
Div Non Decr Years5
CVS.DE Yearly Dividends per shareCVS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 722.81% of the earnings are spent on dividend by CVS. This is not a sustainable payout ratio.
  • CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP722.81%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
CVS.DE Yearly Income VS Free CF VS DividendCVS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B
CVS.DE Dividend Payout.CVS.DE Dividend Payout, showing the Payout Ratio.CVS.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CVS HEALTH CORP

FRA:CVS (2/13/2026, 7:00:00 PM)

66.27

-0.06 (-0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-10
Earnings (Next)04-29
Inst Owners89.6%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap84.13B
Revenue(TTM)N/A
Net Income(TTM)469.00M
Analysts80
Price Target80.19 (21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.41%
Yearly Dividend2.23
Dividend Growth(5Y)5.72%
DP722.81%
Div Incr Years3
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.34%
Min EPS beat(2)15.69%
Max EPS beat(2)22.99%
EPS beat(4)4
Avg EPS beat(4)24.17%
Min EPS beat(4)15.69%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)6.87%
EPS beat(12)10
Avg EPS beat(12)5.67%
EPS beat(16)14
Avg EPS beat(16)5.3%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)3.04%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.97%
Revenue beat(12)9
Avg Revenue beat(12)1.97%
Revenue beat(16)13
Avg Revenue beat(16)2.12%
PT rev (1m)-2.65%
PT rev (3m)7.9%
EPS NQ rev (1m)0.25%
EPS NQ rev (3m)3.18%
EPS NY rev (1m)0.04%
EPS NY rev (3m)2.01%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)1.09%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.52%
Valuation
Industry RankSector Rank
PE 11.65
Fwd PE 10.86
P/S 0.25
P/FCF 15.86
P/OCF 10.96
P/B 1.37
P/tB N/A
EV/EBITDA N/A
EPS(TTM)5.69
EY8.59%
EPS(NY)6.1
Fwd EY9.21%
FCF(TTM)4.18
FCFY6.31%
OCF(TTM)6.05
OCFY9.13%
SpS261.71
BVpS48.43
TBVpS-25.59
PEG (NY)1.6
PEG (5Y)N/A
Graham Number78.74
Profitability
Industry RankSector Rank
ROA 0.18%
ROE 0.64%
ROCE 6.61%
ROIC 4.9%
ROICexc 5.26%
ROICexgc 19.51%
OM 2.73%
PM (TTM) 0.12%
GM 13.88%
FCFM 1.6%
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexgc growth 3Y-10.65%
ROICexgc growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
F-Score6
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 10.46
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.71%
Interest Coverage -3.53
Cash Conversion N/A
Profit Quality 1341.79%
Current Ratio 0.83
Quick Ratio 0.63
Altman-Z 2.26
F-Score6
WACC7.66%
ROIC/WACC0.64
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)24.54%
EPS 3Y-8.11%
EPS 5Y-2.11%
EPS Q2Q%-8.4%
EPS Next Y7.28%
EPS Next 2Y10.96%
EPS Next 3Y11.47%
EPS Next 5Y9.08%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%8.17%
Revenue Next Year2.59%
Revenue Next 2Y3.98%
Revenue Next 3Y5.31%
Revenue Next 5Y4.26%
EBIT growth 1Y-3.81%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year46.78%
EBIT Next 3Y19.74%
EBIT Next 5Y17.54%
FCF growth 1Y-44.32%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-35.44%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%

CVS HEALTH CORP / CVS.DE FAQ

What is the fundamental rating for CVS stock?

ChartMill assigns a fundamental rating of 3 / 10 to CVS.DE.


What is the valuation status of CVS HEALTH CORP (CVS.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CVS HEALTH CORP (CVS.DE). This can be considered as Fairly Valued.


What is the profitability of CVS stock?

CVS HEALTH CORP (CVS.DE) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for CVS stock?

The Earnings per Share (EPS) of CVS HEALTH CORP (CVS.DE) is expected to grow by 7.28% in the next year.


Can you provide the dividend sustainability for CVS stock?

The dividend rating of CVS HEALTH CORP (CVS.DE) is 6 / 10 and the dividend payout ratio is 722.81%.